Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
Top Middle East leaders – Christoph Mares Boutique Group
“I Am Hanna” – A Chihuahua’s Story of Redemption
Edward Avanessy Introduces Kiki Coto, a Story of Justice, Karma and the Soul
The Wait Is Almost Over: D.A. Etheridge Prepares to Unleash The Muddy River Blues
Sunqix Energy INC Global Development Blueprint
Sunqix Energy INC Aligns Green Energy Development with Social Value
Sunqix Energy INC Builds a Global Renewable Energy Partnership Ecosystem
Sunqix Energy INC Builds an Intelligent Solar Operations System
Sunqix Energy INC Launches Its South America Strategy
Rosely AI Social Media Launches Reel Integration For Customized AI Characters
Bitensity Advances Its Vision for Blockchain-Powered E-Commerce Payments
From Childhood Trauma to Purpose: Marion Welch Unveils “One Decision at a Time”
Marion Welch Releases One Decision at a Time, a Memoir on Building Resilience Through Deliberate Choice
Everion Pharmaceuticals Appoints Multilingual International Executive Alina Khomenko as Chief Operating Officer
Wenjin to Present Market-Specific Helmet Development and OEM Solutions at EICMA 2026
TetherMax Highlights Ongoing WOO X Pro and Binance Campaigns
A Journey Through Laughter, Loss, and Resilience – Eric Noriega Debuts Mi Grandulon: Poetry and Short
One Mother’s Fight to Turn Devastating Loss Into Lasting Love
A Mother’s Love Crosses Every Border: Doreen Evette Carroll Shares a Story of Loss, Faith, and Healing in A Mother’s Journey: From Loss to Love
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute